Feike Jeffrey L. 4
4 · Tevogen Bio Holdings Inc. · Filed Dec 26, 2024
Insider Transaction Report
Form 4
Feike Jeffrey L.
Director
Transactions
- Award
Common Stock
2024-12-23+240,000→ 821,771 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments beginning on January 1, 2025, provided that the reporting person remains in service with the Issuer at such dates. Each RSU represents a contingent right to receive one share of the Issuer's common stock.